DESIPRAMINE 75 MG — DIN 02216272
DESIPRAMINE HYDROCHLORIDE : 75 MG · AA PHARMA INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is DESIPRAMINE?
DESIPRAMINE 75 MG contains DESIPRAMINE HYDROCHLORIDE : 75 MG. It is listed in the Health Canada Drug Product Database under DIN 02216272, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Dec-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DESIPRAMINE used for?
Treatment of endogenous depressive illness (manic depressive illness, involutional melancholia, psychotic depression) and non-psychotic depressive neurosis. Not for normal grief reactions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Desipramine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
14 holders have a Canadian DIN containing Desipramine, across 49 DINs, of which 5 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 5 | 5 | DESIPRAMINE | Sourceable in Canada |
| APOTEX INC | 5 | 0 | DESIPRAMINE | No marketed DIN |
| PHARMASCIENCE INC | 5 | 0 | PMS DESIPRAMINE HYDRO TAB 10MG, PMS DESIPRAMINE HYDRO TAB 25MG, PMS DESIPRAMINE HYDRO TAB 50MG, PMS DESIPRAMINE HYDRO TAB 75MG, PMS-DESIPRAMINE - TAB 100MG | No marketed DIN |
| PHARMEL INC | 5 | 0 | PHL-DESIPRAMINE | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 5 | 0 | RATIO-DESIPRAMINE TAB 100MG, RATIO-DESIPRAMINE TAB 10MG, RATIO-DESIPRAMINE TAB 25MG, RATIO-DESIPRAMINE TAB 50MG, RATIO-DESIPRAMINE TAB 75MG | No marketed DIN |
| NOVOPHARM LIMITED | 4 | 0 | NOVO-DESIPRAMINE FC - 50MG TAB, NOVO-DESIPRAMINE SC - TAB 10MG, NOVO-DESIPRAMINE SC - TAB 25MG, NOVO-DESIPRAMINE SC -TAB 75MG | No marketed DIN |
| PENTAPHARM LTD. | 4 | 0 | PENTA-DESIPRAMINE TABLETS | No marketed DIN |
| PRO DOC LIMITEE | 4 | 0 | DESIPRAMINE-10 - TAB 10MG, DESIPRAMINE-25 - TAB 25MG, DESIPRAMINE-50 - TAB 50MG, DESIPRAMINE-75 - TAB 75MG | No marketed DIN |
| AVENTIS PHARMA INC | 3 | 0 | NORPRAMIN 100MG TAB, NORPRAMIN 10MG TAB, NORPRAMIN 75MG TAB | No marketed DIN |
| MERRELL PHARMS INC., DIVISION OF MERRELL DOW (CAN) | 3 | 0 | NORPRAMIN TAB 25MG, NORPRAMIN TAB 50MG, NORPRAMIN TAB 75MG | No marketed DIN |
| DOMINION PHARMACAL | 2 | 0 | DOM-DESIPRAMINE TABLETS - 25MG, DOM-DESIPRAMINE TABLETS - 50MG | No marketed DIN |
| SANOFI-AVENTIS CANADA INC | 2 | 0 | NORPRAMIN 25MG TAB, NORPRAMIN 50MG TAB | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 75 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Bottles of 100 tablets. |
| Storage | Storage in the home must be supervised responsibly; dispense in child-resistant containers. (Specific temperature range not provided in text). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Desipramine |
|---|---|
| ATC code | N06AA01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02216272 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2216272 |
| Brand name | DESIPRAMINE |
| Generic / active ingredient | DESIPRAMINE HYDROCHLORIDE : 75 MG |
| Market authorization holder | AA PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | N06AA01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N06AA |
| Current status | MARKETED |
| Status date | 16-Dec-2022 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: Start 25-50 mg/day, increase to 100-200 mg/day (max 300 mg). Elderly: 25-100 mg/day (max 150 mg). May be single or divided doses. Swallow tablets with water.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Concomitant use with MAOIs (within 2 weeks); acute recovery period after myocardial infarction; poorly controlled cardiac decompensation; hypersensitivity to desipramine or dibenzazepines.
Warnings and precautions
Extreme caution in cardiovascular disease (arrhythmias, stroke, MI), history of urinary retention/glaucoma, thyroid disease, and seizure disorders. Risk of suicidal ideation/behavior.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
5 of 49 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DESIPRAMINE | 25 MG | TABLET | AA PHARMA INC | MARKETED | 02216256 |
| DESIPRAMINE | 10 MG | TABLET | AA PHARMA INC | MARKETED | 02216248 |
| DESIPRAMINE | 50 MG | TABLET | AA PHARMA INC | MARKETED | 02216264 |
| DESIPRAMINE | 100 MG | TABLET | AA PHARMA INC | MARKETED | 02216280 |
| DESIPRAMINE | 10 MG | TABLET | APOTEX INC | APPROVED | 02211939 |
| DESIPRAMINE | 75 MG | TABLET | APOTEX INC | APPROVED | 02211963 |
| DESIPRAMINE | 25 MG | TABLET | APOTEX INC | APPROVED | 02211947 |
| DESIPRAMINE | 50 MG | TABLET | APOTEX INC | APPROVED | 02211955 |
| DESIPRAMINE | 100 MG | TABLET | APOTEX INC | APPROVED | 02211971 |
| DESIPRAMINE-10 - TAB 10MG | 10 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 02222981 |
2 · Same class — other molecules in ATC N06AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Doxepin | ALTI-DOXEPIN - CAP 10MG · ALTI-DOXEPIN-CAP 25MG · ALTI-DOXEPIN-CAP 50MG · ALTI-DOXEPIN-CAP 75MG · +22 more | 51 | 22 | Yes |
| Amitriptyline | AG-AMITRIPTYLINE · AMITRIPTYLINE · AMITRIPTYLINE 10 TAB · AMITRIPTYLINE 25 TAB · +28 more | 83 | 15 | Yes |
| Imipramine | APO-IMIPRAMINE · APO-IMIPRAMINE TABLETS · IMIPRAMINE 10TAB · IMIPRAMINE 25TAB · +16 more | 32 | 8 | Yes |
| Desipramine | DESIPRAMINE · DESIPRAMINE-10 - TAB 10MG · DESIPRAMINE-25 - TAB 25MG · DESIPRAMINE-50 - TAB 50MG · +29 more | 49 | 5 | Yes |
| Clomipramine | ACT CLOMIPRAMINE · ALTIUS-CLOMIPRAMINE · ANAFRANIL · APO-CLOMIPRAMINE · +19 more | 35 | 5 | Yes |
| Trimipramine | APO-TRIMIPRAMINE · NOVO-TRIPRAMINE TAB 100MG BP · NOVO-TRIPRAMINE TAB 25MG BP · NOVO-TRIPRAMINE TAB 50MG BP · +15 more | 32 | 5 | Yes |
| Nortriptyline | APO-NORTRIPTYLINE · AVA-NORTRIPTYLINE · AVENTYL · DOM-NORTRIPTYLINE 10MG CAPSULES · +10 more | 24 | 2 | Yes |
| Maprotiline | LUDIOMIL TAB 10MG · LUDIOMIL TAB 25MG · LUDIOMIL TAB 50MG · LUDIOMIL TAB 75MG · +3 more | 12 | 0 | Not in Canada |
| Amoxapine | ASENDIN - TAB 100MG · ASENDIN - TAB 25MG · ASENDIN - TAB 50MG · ASENDIN TAB 100MG · +2 more | 6 | 0 | Not in Canada |
| Protriptyline | TRIPTIL TAB 10MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N06AB | Citalopram · Escitalopram · Fluoxetine · Fluvoxamine · Paroxetine · +1 more | 589 | 248 |
| N06AX | Bupropion · Desvenlafaxine · Duloxetine · Esketamine · Levomilnacipran · +7 more | 386 | 181 |
| N06AG | Moclobemide | 21 | 4 |
| N06AF | Tranylcypromine | 2 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.